Skip to main content Back to Top
Advertisement

9/8/2022

Losartan Tablets

Reason for the Shortage

    • Beginning in mid-2018, FDA found that several angiotensin II receptor blocker (ARB) medicines contained nitrosamine impurities and have been recalled because they do not meet FDA's safety standards. Additional information including a list of affected lots can be found at https://www.fda.gov/drugs/drug-safety-and-availability/recalls-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and-irbesartan.
    • Camber, Avet, Teva, and Torrent were affected by the recall.
    • Alembic has product available for current customers.
    • Aurobindo refuses to provide updated availability information.
    • Avet discontinued losartan tablets in 2021.
    • Cadista has temporarily discontinued losartan tablets due to issues with obtaining active ingredient. The company cannot estimate when the product will be relaunched.
    • Camber has losartan tablets available.
    • Lupin has losartan tablets available.
    • Major has losartan tablets available.
    • Merck divested Cozaar to Organon. Their NDCs were changed in late-2021.
    • Organon has Cozaar available.
    • Torrent discontinued losartan tablets in late-2021.
    • Zydus has losartan tablets available.

Available Products

    • Cozaar oral tablet, Organon, 100 mg, bottle, 30 count, NDC 78206-0123-01
    • Cozaar oral tablet, Organon, 100 mg, bottle, 90 count, NDC 78206-0123-02
    • Cozaar oral tablet, Organon, 25 mg, bottle, 90 count, NDC 78206-0121-01
    • Cozaar oral tablet, Organon, 50 mg, bottle, 30 count, NDC 78206-0122-01
    • Cozaar oral tablet, Organon, 50 mg, bottle, 90 count, NDC 78206-0122-02
    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 30 count, NDC 62332-0029-30
    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 90 count, NDC 62332-0029-90
    • Losartan potassium oral tablet, Alembic, 100 mg, bottle, 1000 count, NDC 62332-0029-91
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 30 count, NDC 62332-0027-30
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 90 count, NDC 62332-0027-90
    • Losartan potassium oral tablet, Alembic, 25 mg, bottle, 1000 count, NDC 62332-0027-91
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 30 count, NDC 62332-0028-30
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 90 count, NDC 62332-0028-90
    • Losartan potassium oral tablet, Alembic, 50 mg, bottle, 1000 count, NDC 62332-0028-91
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 30 count, NDC 31722-0702-30
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 90 count, NDC 31722-0702-90
    • Losartan potassium oral tablet, Camber, 100 mg, bottle, 1000 count, NDC 31722-0702-10
    • Losartan potassium oral tablet, Camber, 25 mg, bottle, 90 count, NDC 31722-0700-90
    • Losartan potassium oral tablet, Camber, 25 mg, bottle, 1000 count, NDC 31722-0700-10
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 30 count, NDC 31722-0701-30
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 90 count, NDC 31722-0701-90
    • Losartan potassium oral tablet, Camber, 50 mg, bottle, 1000 count, NDC 31722-0701-10
    • Losartan potassium oral tablet, Lupin, 100 mg, bottle, 90 count, NDC 68180-0378-09
    • Losartan potassium oral tablet, Lupin, 100 mg, bottle, 1000 count, NDC 68180-0378-03
    • Losartan potassium oral tablet, Lupin, 25 mg, bottle, 90 count, NDC 68180-0376-09
    • Losartan potassium oral tablet, Lupin, 25 mg, bottle, 1000 count, NDC 68180-0376-03
    • Losartan potassium oral tablet, Lupin, 50 mg, bottle, 90 count, NDC 68180-0377-09
    • Losartan potassium oral tablet, Lupin, 50 mg, bottle, 1000 count, NDC 68180-0377-03
    • Losartan potassium oral tablet, Major, 100 mg, unit-dose blister pack, 100 count, NDC 00904-7049-61
    • Losartan potassium oral tablet, Major, 25 mg, unit-dose blister pack, 100 count, NDC 00904-7047-61
    • Losartan potassium oral tablet, Major, 50 mg, unit-dose blister pack, 100 count, NDC 00904-7048-61
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 30 count, NDC 68382-0137-06
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 90 count, NDC 68382-0137-16
    • Losartan potassium oral tablet, Zydus, 100 mg, bottle, 1000 count, NDC 68382-0137-10
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 30 count, NDC 68382-0135-06
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 90 count, NDC 68382-0135-16
    • Losartan potassium oral tablet, Zydus, 25 mg, bottle, 1000 count, NDC 68382-0135-10
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 30 count, NDC 68382-0136-06
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 90 count, NDC 68382-0136-16
    • Losartan potassium oral tablet, Zydus, 50 mg, bottle, 1000 count, NDC 68382-0136-10

Updated

Updated September 8, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 7, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT